Tag: biotechnology
-
Two Venture Funds Unveiled for Science Start-Ups
Two investment companies announced venture capital funds totaling nearly $700 million for supporting new life science and health technology businesses.
-
AI-Aided Cancer Analytics Gain $21.5M in Early Funds
A start-up enterprise using artificial intelligence algorithms to analyze tumor biopsy images is raising $21.5 million in seed and first-round venture funding.
-
Hydrogel Shown to Boost Beneficial Gut Microbes
Tests with lab mice show a highly absorbent biocompatible gel promotes the growth of beneficial microbes associated with good metabolic health.
-
State Grant Funds Virus-Immunotherapy Cancer Trial
A California state agency is helping fund a clinical trial testing an immunotherapy combined with a cancer-killing virus to treat solid tumor cancers.
-
Early Trials Show Responses for Some Blood Cancers
First results from two clinical trials testing the safety of natural killer cell therapies show responses by patients with some forms of blood-related cancers.
-
Infographic – US Biotech Venture Deals Slow in Q1
The rate of new venture deals for biotechnology start-ups in the U.S. slowed in the first quarter of 2022, but total dollars invested remain on track from last year.
-
Ginkgo Acquires Bayer Agricultural Biologics Technology
Synthetic biology developer Ginkgo Bioworks is acquiring agricultural biologics assets from Bayer, transforming the companies’ five-year partnership.
-
Trial Begins Testing Crispr Gut Microbiome Therapy
A clinical trial is underway assessing a genetically edited oral drug designed to remove E. coli in the gut, a danger for patients with blood-related cancers.
-
Cystic Fibrosis Start-Up Raises $111M in New Funds
A developer of new treatments for the inherited lung disease cystic fibrosis emerged from stealth mode, raising $111 million in new venture funds.
-
Trial Set for Gut Infection Biologic Treatment
A developer of biologic therapies for gastrointestinal disorders says FDA cleared its request for a clinical trial testing its treatment for C. difficile.